Logo image of SANG

SANGOMA TECHNOLOGIES CORP (SANG) Stock Fundamental Analysis

USA - NASDAQ:SANG - CA80100R4089 - Common Stock

5.17 USD
-0.05 (-0.96%)
Last: 9/19/2025, 8:00:02 PM
5 USD
-0.17 (-3.29%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SANG. SANG was compared to 48 industry peers in the Communications Equipment industry. Both the profitability and financial health of SANG have multiple concerns. SANG is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SANG had negative earnings in the past year.
In the past year SANG had a positive cash flow from operations.
In the past 5 years SANG reported 4 times negative net income.
Of the past 5 years SANG 4 years had a positive operating cash flow.
SANG Yearly Net Income VS EBIT VS OCF VS FCFSANG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

SANG has a Return On Assets of -1.92%. This is comparable to the rest of the industry: SANG outperforms 47.92% of its industry peers.
SANG's Return On Equity of -2.71% is in line compared to the rest of the industry. SANG outperforms 54.17% of its industry peers.
Industry RankSector Rank
ROA -1.92%
ROE -2.71%
ROIC N/A
ROA(3y)-10.31%
ROA(5y)-5.73%
ROE(3y)-17.31%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
SANG Yearly ROA, ROE, ROICSANG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

SANG has a Gross Margin of 68.63%. This is amongst the best in the industry. SANG outperforms 93.75% of its industry peers.
SANG's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SANG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.76%
SANG Yearly Profit, Operating, Gross MarginsSANG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

SANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SANG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SANG Yearly Shares OutstandingSANG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
SANG Yearly Total Debt VS Total AssetsSANG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that SANG is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SANG (1.03) is comparable to the rest of the industry.
SANG has a debt to FCF ratio of 1.71. This is a very positive value and a sign of high solvency as it would only need 1.71 years to pay back of all of its debts.
The Debt to FCF ratio of SANG (1.71) is better than 64.58% of its industry peers.
SANG has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
SANG has a Debt to Equity ratio of 0.16. This is comparable to the rest of the industry: SANG outperforms 54.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.71
Altman-Z 1.03
ROIC/WACCN/A
WACC9.03%
SANG Yearly LT Debt VS Equity VS FCFSANG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

SANG has a Current Ratio of 0.87. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.87, SANG is doing worse than 91.67% of the companies in the same industry.
SANG has a Quick Ratio of 0.87. This is a bad value and indicates that SANG is not financially healthy enough and could expect problems in meeting its short term obligations.
SANG has a worse Quick ratio (0.69) than 85.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.69
SANG Yearly Current Assets VS Current LiabilitesSANG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.15% over the past year.
EPS 1Y (TTM)46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.58%

3.2 Future

The Earnings Per Share is expected to grow by 155.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.78% on average over the next years.
EPS Next Y132.46%
EPS Next 2Y155.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y3.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SANG Yearly Revenue VS EstimatesSANG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SANG Yearly EPS VS EstimatesSANG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

SANG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 113.75, which means the current valuation is very expensive for SANG.
SANG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SANG is more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SANG to the average of the S&P500 Index (22.86), we can say SANG is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 113.75
SANG Price Earnings VS Forward Price EarningsSANG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

97.92% of the companies in the same industry are more expensive than SANG, based on the Enterprise Value to EBITDA ratio.
SANG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SANG is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.72
EV/EBITDA 5.01
SANG Per share dataSANG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SANG's earnings are expected to grow with 155.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y155.83%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SANG!.
Industry RankSector Rank
Dividend Yield N/A

SANGOMA TECHNOLOGIES CORP

NASDAQ:SANG (9/19/2025, 8:00:02 PM)

After market: 5 -0.17 (-3.29%)

5.17

-0.05 (-0.96%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)09-17 2025-09-17/amc
Earnings (Next)11-04 2025-11-04
Inst Owners25.14%
Inst Owner Change-16.65%
Ins Owners26.88%
Ins Owner ChangeN/A
Market Cap171.90M
Analysts80
Price Target8.29 (60.35%)
Short Float %0.03%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-114.52%
Min EPS beat(2)-197.03%
Max EPS beat(2)-32.01%
EPS beat(4)0
Avg EPS beat(4)-79.27%
Min EPS beat(4)-197.03%
Max EPS beat(4)-8.01%
EPS beat(8)2
Avg EPS beat(8)-71.23%
EPS beat(12)4
Avg EPS beat(12)-370.85%
EPS beat(16)5
Avg EPS beat(16)-310.58%
Revenue beat(2)0
Avg Revenue beat(2)-5.04%
Min Revenue beat(2)-7.66%
Max Revenue beat(2)-2.42%
Revenue beat(4)0
Avg Revenue beat(4)-3.65%
Min Revenue beat(4)-7.66%
Max Revenue beat(4)-1.26%
Revenue beat(8)2
Avg Revenue beat(8)-2.24%
Revenue beat(12)3
Avg Revenue beat(12)-2.11%
Revenue beat(16)7
Avg Revenue beat(16)0.99%
PT rev (1m)3.46%
PT rev (3m)-0.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)86.67%
EPS NY rev (1m)4.9%
EPS NY rev (3m)4.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 113.75
P/S 0.72
P/FCF 4.72
P/OCF 3.71
P/B 0.67
P/tB N/A
EV/EBITDA 5.01
EPS(TTM)-0.14
EYN/A
EPS(NY)0.05
Fwd EY0.88%
FCF(TTM)1.1
FCFY21.21%
OCF(TTM)1.39
OCFY26.97%
SpS7.17
BVpS7.68
TBVpS-1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.92%
ROE -2.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.63%
FCFM 15.3%
ROA(3y)-10.31%
ROA(5y)-5.73%
ROE(3y)-17.31%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.76%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.71
Debt/EBITDA 0.91
Cap/Depr 21.7%
Cap/Sales 4.16%
Interest Coverage N/A
Cash Conversion 106.35%
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.69
Altman-Z 1.03
F-Score5
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)20.7%
Cap/Depr(5y)19.74%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y132.46%
EPS Next 2Y155.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.58%
Revenue Next Year2.38%
Revenue Next 2Y3.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4302.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y156.57%
FCF growth 3Y28.15%
FCF growth 5Y37.43%
OCF growth 1Y84.13%
OCF growth 3Y33.68%
OCF growth 5Y38.57%